14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
WLTH vs CHYM: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Chime Financial, Inc. (CHYM) is the stronger overall head-to-head candidate over WLTH (WLTH) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). WLTH carries a Unified Composite Score of 50.7/100 (HOLD) at $10.76 (N/M Forward P/E, N/A operating margin), whereas CHYM carries 33.1/100 (SELL) at $34.48 (30.9x Forward P/E, 19.3% operating margin).
Composite vs. Pillar Nuance: While WLTH currently prints a higher short-term Unified Composite Score (50.7/100 HOLD vs. CHYM 33.1/100 SELL), CHYM captures the overall institutional head-to-head verdict (9–1 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (19.3% vs. N/A operating margin) and revenue trajectory (+32.1% vs. N/A YoY).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on WLTH vs CHYM. Trailing 12-month operating profitability (WLTH N/A vs CHYM 19.3%) and valuation multiples (WLTH N/M vs CHYM 30.9x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Software - Application value chain with $12.7B market capitalization and 19.3% operating margin.
OpEx & R&D Reinvestment70.1% of Rev ($10.1B)
90D Engineering Disclosures0 Published
Investor FAQ WLTH vs CHYM Key Questions & Quantitative Answers
As of Nov 16, 2026, Chime Financial, Inc. (CHYM) is the stronger overall head-to-head candidate over WLTH (WLTH) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). WLTH carries a Unified Composite Score of 50.7/100 (HOLD) at $10.76 (N/M Forward P/E, N/A operating margin), whereas CHYM carries 33.1/100 (SELL) at $34.48 (30.9x Forward P/E, 19.3% operating margin). Composite vs. Pillar Nuance: While WLTH currently prints a higher short-term Unified Composite Score (50.7/100 HOLD vs. CHYM 33.1/100 SELL), CHYM captures the overall institutional head-to-head verdict (9–1 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (19.3% vs. N/A operating margin) and revenue trajectory (+32.1% vs. N/A YoY).
CHYM leads the Growth & Scale pillar: WLTH posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with CHYM at +32.1% YoY revenue growth and -33.8% YoY earnings growth on $14.3B TTM revenue (89.4% gross margin, 19.3% operating margin). On trailing 12-month operating scale, WLTH generates N/A in USD-normalized revenue versus $14.3B for CHYM. In operating R&D and SG&A reinvestment, WLTH deploys N/A (0 90-day corporate R&D disclosures) versus 70.1% of Rev ($10.1B) (0 disclosures) for CHYM.
CHYM screens cheaper on headline valuation multiples. WLTH trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas CHYM trades at 30.9x Forward P/E, 29.0x Trailing P/E, N/M PEG, and 0.7x EV/Revenue (15.8% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against WLTH (N/A ROE) versus CHYM (5.4% ROE) capital efficiency.
In options market volatility and institutional positioning, WLTH carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.96β · 53% Vol realized risk). By comparison, CHYM carries 50.0% implied volatility (15th %ile, Compressed (<25th %ile)), a 0.22x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.45β · 36% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.